Loading
Minuteman Therapeutics
Minuteman Therapeutics develops oncolytic viruses engineered against an individual patient's tumour, matching the virus to the biology of that person's cancer.
Also called: Minuteman Tx
Overview
Oncolytic viruses infect and kill cancer cells and alert the immune system to them; talimogene laherparepvec is the approved example. Minuteman's stated approach is personalised: an oncolytic virus designed against the individual patient's tumour rather than one product for all. It is an Even One Ventures portfolio company with no published trials.
Headquarters
United States (head office not published), US
Funding
All startupsStartup
Investors
Type
Stage
Startup
Website
Connected
2Similar pages
- CompanyRanata Therapeutics
Shares Even One Ventures and the tags startup, evenone-portfolio, oncology.
- CompanyRelit Biosciences
Shares Even One Ventures and the tags startup, evenone-portfolio, oncology.
- CompanyEcho Immune
Shares Even One Ventures and the tags startup, evenone-portfolio, oncology.
- CompanyInvocata
Shares Even One Ventures and the tags startup, evenone-portfolio, oncology.
- CompanyYuga Bio
Shares Even One Ventures and the tags startup, evenone-portfolio, oncology.
- CompanyKernis Health
Shares Even One Ventures and the tags startup, evenone-portfolio, oncology.
- CompanyPalitra Bio
Shares Even One Ventures and the tags startup, evenone-portfolio, oncology.
- CompanyArden Bio
Shares Even One Ventures and the tags startup, evenone-portfolio.
technologies
companies
Sources
Every source this page cites, grouped by who published it. Grouping is read from the web address, not assigned by hand.
evenone.ventures · 1
minuteman.bio · 1
A source that has moved or gone is reported by the weekly link check. /audit/